Your browser doesn't support javascript.
loading
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles.
Sanaei, Mohammad-Javad; Razi, Sara; Pourbagheri-Sigaroodi, Atieh; Bashash, Davood.
Affiliation
  • Sanaei MJ; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Razi S; Department of Biology, Science and Research branch, Islamic Azad University, Tehran, Iran.
  • Pourbagheri-Sigaroodi A; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Bashash D; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: D.bashash@sbmu.ac.ir.
Transl Oncol ; 18: 101364, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35168143
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Oncol Year: 2022 Document type: Article Affiliation country: Irán
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Oncol Year: 2022 Document type: Article Affiliation country: Irán